Is there a role of MOG antibodies in idiopathic intracranial hypertension: A comparative analysis with optic neuritis-MOG antibody associated disease
Authors:
- 6 December 2025
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 106, 106910
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- MOGAD presenting as fulminant intracranial hypertensionJournal of Neuroimmunology, 2024
- Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)European Journal of Paediatric Neurology, 2023
- Overlap and Differences in Migraine and Idiopathic Intracranial HypertensionCurrent Pain and Headache Reports, 2023
- Paediatric MOG-antibody disease presenting with intracranial hypertension and unilateral vision loss without radiological evidence of optic neuritisJournal of Neuroimmunology, 2023
- Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated diseaseMultiple Sclerosis and Related Disorders, 2021
- Cerebrospinal fluid dynamics in idiopathic intracranial hypertension: a literature review and validation of contemporary findingsActa Neurochirurgica, 2021
- Idiopathic Intracranial Hypertension and Multiple SclerosisMultiple Sclerosis and Related Disorders, 2021
- Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorderJournal of Neurology, 2020
- Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and OutcomeAmerican Journal of Ophthalmology, 2018
- Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentationJournal of Neurology, 2018